Fabrazyme agalsidase beta: Post-marketing study started

Genzyme began the 5-year, international post-marketing FIELD trial to evaluate 0.5 mg/kg Fabrazyme given every 2 weeks or 1 mg/kg Fabrazyme given every 4 weeks in male patients ages 5-18. Fabrazyme is...